Patent · US Active

Pharmaceutical composition

US10363324B2 · kind B2 · utility

0Cited by

3References

6Claims

0Family size

Assignees

The South African Nuclear Energy Corporation Limited · ZA
North-West University · ZA

Inventors

Anne Frederica Grobler · Potchefstroom, ZA
Jan Rijn Zeevaart · Pretoria, ZA

Key dates

Filing date	Nov 4, 2014
Grant date	Jul 30, 2019
Priority date	—
Expiry date	Nov 4, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K51/1244
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to a pharmaceutical composition for parenteral or oral administration containing a radioactive compound which can be used diagnostically or therapeutically. The composition comprises a micro-emulsion constituted by a dispersion of vesicles or microsponges of a fatty acid based component in an aqueous or other pharmacologically acceptable carrier in which nitrous oxide is dissolved, the fatty acid based component comprising at least one long chain fatty acid based substance selected from the group consisting of free fatty acids and derivatives of free fatty acids, and the radioactive compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.